Healthcare Providers and Services
Company Overview of National Institutes of Health
National Institutes of Health operates as a medical research agency in the United States. It offers services for conducting and supporting basic, clinical, and translational medical research; and investigates the causes, treatments, and cures for common and rare diseases. The company also provides leadership and direction to programs designed to improve the health by conducting and supporting research in the causes, diagnosis, prevention, and cure of human diseases; in the processes of human growth and development; in the biological effects of environmental contaminants; in the understanding of mental, addictive, and physical disorders; and in directing programs for the collection, dissemina...
9000 Rockville Pike
Bethesda, MD 20892
Founded in 1887
Key Executives for National Institutes of Health
Chief Financial Officer and Deputy Director of Management
Chief Information Officer
Deputy Director of Extramural Research
Compensation as of Fiscal Year 2014.
National Institutes of Health Key Developments
National Institutes of Health Presents at Milken Institute, Global Conference 2015, Apr-26-2015
Apr 16 15
National Institutes of Health Presents at Milken Institute, Global Conference 2015, Apr-26-2015. Venue: 2025 Ave Of The Stars, Los Angeles, CA 90067, California, United States. Presentation Date & Speakers: Apr-27-2015, Francis S. Collins, Director.
The National Institute of Health Awards Daktari Diagnostics with $1.2 Million Grant for Phase II Small Business Innovation Research
Mar 10 15
The National Institute of Health has awarded a Phase II Small Business Innovation Research (SBIR) grant to Daktari Diagnostics for development of a point-of-care hepatitis C diagnostic, following onto the Phase I grant awarded in June 2014 as part of the NIH SBIR Fast Track program. The Phase II grant, for $1.2 million, funds efforts in antibody science and microfluidics engineering to make the hepatitis C virus (HCV) viral load test fast and portable, enabling it to impact care in remote areas.
Lion Biotechnologies, Inc. Obtains Exclusive License from National Institutes of Health to Develop and Commercialize TIL Therapy in Metastatic Melanoma
Feb 10 15
Lion Biotechnologies Inc. announced that it has obtained an exclusive, worldwide license from the National Institute of Health (NIH) to certain patents to develop and commercialize TIL therapy in the treatment of metastatic melanoma. The exclusive license was obtained through an amendment to Lion's previously granted, non-exclusive, worldwide license to certain NIH issued and pending patent applications for the use of TIL in the treatment of metastatic melanoma.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|